Delivery Order SPE2DB20D3101-SPE2DB25FRVH3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.92 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a direct procurement of pharmaceutical supplies to support military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on September 4, 2025, with a ceiling value of $1,616.16 and completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s, with a ceiling value of $12,946.57. This firm fixed-price delivery order, which is due for completion by July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 36,000 units of Creon DR 100s capsules. This competitively awarded, firm fixed-price delivery order has a ceiling value of $17,155.37 and is scheduled for completion by August 5, 2025. The contract does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Creon DR 36,000 unit capsules in units of 100, with a contract ceiling value of $2,335.13 and an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 24,000 unit capsules of Creon DR 100s, with a ceiling value of $8,755.73 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by August...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Creon DR 36,000 unit capsules in 100-count packages, with a contract value of $3,339.59 and completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award supporting federal pharmaceutical procurement needs. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 24,000 units of Creon DR 100s capsules, with a contract ceiling value of $7,467.22. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVH3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 36,000 units of Creon DR capsules (100s formulation) with a ceiling value of $7,070.70. This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract was competitively awarded and demonstrates the contractor's capability to meet federal procurement requirements for specialized medications, including gastrointestinal treatments such as Creon, as part of its extensive portfolio serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/12/25 |